Sjögren C
Department of Pharmacology, Aktiebolaget Leo Research Laboratories, Helsingborg, Sweden.
Arzneimittelforschung. 1987 Sep;37(9):1017-20.
The influence of lofepramine on the heart has been studied in anaesthetized rats. Lofepramine and other antidepressants were infused i.v. during 4 h at a rate of 0.5 mg/kg/min for lofepramine (equimolar concentrations for the other antidepressants). ECG and survival time were recorded. It was shown that lofepramine in contrast to the other antidepressants tested did not influence the PQ- and QRS-times at all. The other antidepressants tested increased the PQ-time 20-170% and the QRS-time 40-130%. Only the rats in the lofepramine group survived the whole experiment. The occurrence of multiple arrhythmias was low in this study and the difference between the groups was not striking. In further 13 rats the plasma level of desipramine, the main metabolite of lofepramine, after 200 min of lofepramine and 100-135 min of desipramine infusion was measured. The levels of desipramine at that time were found approximately comparable after infusion of the two different substances.
已在麻醉大鼠中研究了洛非帕明对心脏的影响。以0.5毫克/千克/分钟的速率静脉输注洛非帕明和其他抗抑郁药4小时(其他抗抑郁药为等摩尔浓度)。记录心电图和存活时间。结果表明,与所测试的其他抗抑郁药不同,洛非帕明对PQ间期和QRS间期完全没有影响。所测试的其他抗抑郁药使PQ间期增加了20%-170%,使QRS间期增加了40%-130%。只有洛非帕明组的大鼠在整个实验中存活下来。本研究中多重心律失常的发生率较低,且各组之间的差异不显著。在另外13只大鼠中,在输注洛非帕明200分钟和地昔帕明100-135分钟后,测量了洛非帕明的主要代谢产物地昔帕明的血浆水平。在输注两种不同物质后,当时地昔帕明的水平大致相当。